Literature DB >> 17270263

The neutrophil in chronic obstructive pulmonary disease.

Jennifer Kathleen Quint1, Jadwiga Anna Wedzicha.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a complex, heterogeneous collection of conditions characterized by irreversible expiratory airflow limitation. The disease involves a multifaceted progressive inflammatory process leading to the development of mucus hypersecretion, tissue destruction, and disruption to the normal repair and defense mechanisms. The result is increased resistance to airflow in small conducting airways, change in lung compliance, and the premature collapse of airways during expiration that leads to air trapping. Neutrophils are necessary in healthy lungs; they are an important component of innate immunity, protecting healthy individuals against infection. However, in COPD, they play a role in the destructive processes that characterize the disease. They can be responsible for significant damage when they accumulate at sites of inflammation and are harmful to healthy tissue. In recent years, increased understanding of the role of neutrophils has led to improved knowledge of the pathogenesis of COPD and allowed new avenues of treatment to be investigated.

Entities:  

Mesh:

Year:  2007        PMID: 17270263     DOI: 10.1016/j.jaci.2006.12.640

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  56 in total

1.  Lentivirus-mediated ADAM17 RNA interference inhibited interleukin-8 expression via EGFR signaling in lung epithelial cells.

Authors:  Yaqing Li; Jianping Yan; Wulin Xu; Hong Wang; Yingjie Xia
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

2.  SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans.

Authors:  Aili L Lazaar; Lisa E Sweeney; Alexander J MacDonald; Neil E Alexis; Chao Chen; Ruth Tal-Singer
Journal:  Br J Clin Pharmacol       Date:  2011-08       Impact factor: 4.335

3.  Cross-talk between PKA-Cβ and p65 mediates synergistic induction of PDE4B by roflumilast and NTHi.

Authors:  Seiko Susuki-Miyata; Masanori Miyata; Byung-Cheol Lee; Haidong Xu; Hirofumi Kai; Chen Yan; Jian-Dong Li
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

4.  Enhanced airway inflammation and remodeling in adenosine deaminase-deficient mice lacking the A2B adenosine receptor.

Authors:  Yang Zhou; Amir Mohsenin; Eva Morschl; Hays W J Young; Jose G Molina; Wenbin Ma; Chun-Xiao Sun; Hector Martinez-Valdez; Michael R Blackburn
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

5.  Novel cellular targets of AhR underlie alterations in neutrophilic inflammation and inducible nitric oxide synthase expression during influenza virus infection.

Authors:  Jennifer L Head Wheeler; Kyle C Martin; B Paige Lawrence
Journal:  J Immunol       Date:  2012-12-10       Impact factor: 5.422

Review 6.  Pharmacological approaches to regulate neutrophil activity.

Authors:  G R Tintinger; R Anderson; C Feldman
Journal:  Semin Immunopathol       Date:  2013-03-15       Impact factor: 9.623

7.  Systemic Markers of Adaptive and Innate Immunity Are Associated with Chronic Obstructive Pulmonary Disease Severity and Spirometric Disease Progression.

Authors:  Eitan Halper-Stromberg; Jeong H Yun; Margaret M Parker; Ruth Tal Singer; Amit Gaggar; Edwin K Silverman; Sonia Leach; Russell P Bowler; Peter J Castaldi
Journal:  Am J Respir Cell Mol Biol       Date:  2018-04       Impact factor: 6.914

Review 8.  Alveolar epithelial and endothelial cell apoptosis in emphysema: what we know and what we need to know.

Authors:  Mathieu C Morissette; Julie Parent; Julie Milot
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15

9.  Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients.

Authors:  Suzana E Tanni; Nilva Rg Pelegrino; Aparecida Yo Angeleli; Camila Correa; Irma Godoy
Journal:  J Inflamm (Lond)       Date:  2010-06-09       Impact factor: 4.981

10.  High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine.

Authors:  Gang Liu; Jing Wang; Young-Jun Park; Yuko Tsuruta; Emmanuel F Lorne; Xia Zhao; Edward Abraham
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.